Serveur d'exploration sur le renard

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Efficacy in cats of a novel topical combination of fipronil, (S)-methoprene, eprinomectin, praziquantel, against induced infestations of Echinococcus multilocularis.

Identifieur interne : 000086 ( PubMed/Curation ); précédent : 000085; suivant : 000087

Efficacy in cats of a novel topical combination of fipronil, (S)-methoprene, eprinomectin, praziquantel, against induced infestations of Echinococcus multilocularis.

Auteurs : Eric Tielemans [France] ; Coralie Manavella [France] ; Martin Visser [Allemagne] ; S. Theodore Chester [États-Unis] ; Joseph Rosentel [États-Unis]

Source :

RBID : pubmed:24703072

English descriptors

Abstract

Although foxes are the main reservoir of Echinococcus multilocularis, it is recognized that dogs and cats also may become infected. In cats the infection and egg production rates are usually low. Nevertheless, cats are a potential source of transmission of E. multilocularis. Due to the high human medical significance of E. multilocularis infection, it is important in endemic areas that owned cats are dewormed regularly. This paper presents the efficacy results of a new topical formulation, Broadline(®) (Merial) tested against E. multilocularis infection in cats. Two blinded laboratory studies were conducted to evaluate this novel topical combination of fipronil, (S)-methoprene, eprinomectin, and praziquantel against E. multilocularis. In each study, purpose-bred cats were assigned randomly to two treatment groups of 10 cats each: one untreated control group and one group treated at the minimum therapeutic dose of 0.12 mL/kg bodyweight to deliver 10mg fipronil, 12 mg (S)-methoprene, 0.5mg eprinomectin and 10mg praziquantel/kg bodyweight. The cats were inoculated orally with E. multilocularis protoscolices, 22 or 23 days before treatment. Based on necropsy and intestinal worm count, 8 or 11 days after treatment, the two studies confirmed 100% efficacy of Broadline(®) against adult E. multilocularis.

DOI: 10.1016/j.vetpar.2014.02.034
PubMed: 24703072

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24703072

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Efficacy in cats of a novel topical combination of fipronil, (S)-methoprene, eprinomectin, praziquantel, against induced infestations of Echinococcus multilocularis.</title>
<author>
<name sortKey="Tielemans, Eric" sort="Tielemans, Eric" uniqKey="Tielemans E" first="Eric" last="Tielemans">Eric Tielemans</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas, France. Electronic address: eric.tielemans@merial.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Manavella, Coralie" sort="Manavella, Coralie" uniqKey="Manavella C" first="Coralie" last="Manavella">Coralie Manavella</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Visser, Martin" sort="Visser, Martin" uniqKey="Visser M" first="Martin" last="Visser">Martin Visser</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial GmbH, Kathrinenhof Research Center, 83101 Rohrdorf, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Merial GmbH, Kathrinenhof Research Center, 83101 Rohrdorf</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Theodore Chester, S" sort="Theodore Chester, S" uniqKey="Theodore Chester S" first="S" last="Theodore Chester">S. Theodore Chester</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial Limited, Duluth, GA 30096, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Merial Limited, Duluth, GA 30096</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rosentel, Joseph" sort="Rosentel, Joseph" uniqKey="Rosentel J" first="Joseph" last="Rosentel">Joseph Rosentel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial Limited, Duluth, GA 30096, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Merial Limited, Duluth, GA 30096</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24703072</idno>
<idno type="pmid">24703072</idno>
<idno type="doi">10.1016/j.vetpar.2014.02.034</idno>
<idno type="wicri:Area/PubMed/Corpus">000086</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000086</idno>
<idno type="wicri:Area/PubMed/Curation">000086</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000086</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Efficacy in cats of a novel topical combination of fipronil, (S)-methoprene, eprinomectin, praziquantel, against induced infestations of Echinococcus multilocularis.</title>
<author>
<name sortKey="Tielemans, Eric" sort="Tielemans, Eric" uniqKey="Tielemans E" first="Eric" last="Tielemans">Eric Tielemans</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas, France. Electronic address: eric.tielemans@merial.com.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Manavella, Coralie" sort="Manavella, Coralie" uniqKey="Manavella C" first="Coralie" last="Manavella">Coralie Manavella</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Visser, Martin" sort="Visser, Martin" uniqKey="Visser M" first="Martin" last="Visser">Martin Visser</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial GmbH, Kathrinenhof Research Center, 83101 Rohrdorf, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Merial GmbH, Kathrinenhof Research Center, 83101 Rohrdorf</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Theodore Chester, S" sort="Theodore Chester, S" uniqKey="Theodore Chester S" first="S" last="Theodore Chester">S. Theodore Chester</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial Limited, Duluth, GA 30096, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Merial Limited, Duluth, GA 30096</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Rosentel, Joseph" sort="Rosentel, Joseph" uniqKey="Rosentel J" first="Joseph" last="Rosentel">Joseph Rosentel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Merial Limited, Duluth, GA 30096, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Merial Limited, Duluth, GA 30096</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Veterinary parasitology</title>
<idno type="eISSN">1873-2550</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antiparasitic Agents (administration & dosage)</term>
<term>Cat Diseases (drug therapy)</term>
<term>Cats</term>
<term>Drug Combinations</term>
<term>Echinococcosis (drug therapy)</term>
<term>Echinococcosis (veterinary)</term>
<term>Echinococcus multilocularis</term>
<term>Female</term>
<term>Ivermectin (administration & dosage)</term>
<term>Ivermectin (analogs & derivatives)</term>
<term>Male</term>
<term>Methoprene (administration & dosage)</term>
<term>Praziquantel (administration & dosage)</term>
<term>Pyrazoles (administration & dosage)</term>
<term>Random Allocation</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antiparasitic Agents</term>
<term>Ivermectin</term>
<term>Methoprene</term>
<term>Praziquantel</term>
<term>Pyrazoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Ivermectin</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Cat Diseases</term>
<term>Echinococcosis</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en">
<term>Echinococcosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cats</term>
<term>Drug Combinations</term>
<term>Echinococcus multilocularis</term>
<term>Female</term>
<term>Male</term>
<term>Random Allocation</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Although foxes are the main reservoir of Echinococcus multilocularis, it is recognized that dogs and cats also may become infected. In cats the infection and egg production rates are usually low. Nevertheless, cats are a potential source of transmission of E. multilocularis. Due to the high human medical significance of E. multilocularis infection, it is important in endemic areas that owned cats are dewormed regularly. This paper presents the efficacy results of a new topical formulation, Broadline(®) (Merial) tested against E. multilocularis infection in cats. Two blinded laboratory studies were conducted to evaluate this novel topical combination of fipronil, (S)-methoprene, eprinomectin, and praziquantel against E. multilocularis. In each study, purpose-bred cats were assigned randomly to two treatment groups of 10 cats each: one untreated control group and one group treated at the minimum therapeutic dose of 0.12 mL/kg bodyweight to deliver 10mg fipronil, 12 mg (S)-methoprene, 0.5mg eprinomectin and 10mg praziquantel/kg bodyweight. The cats were inoculated orally with E. multilocularis protoscolices, 22 or 23 days before treatment. Based on necropsy and intestinal worm count, 8 or 11 days after treatment, the two studies confirmed 100% efficacy of Broadline(®) against adult E. multilocularis.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24703072</PMID>
<DateCreated>
<Year>2014</Year>
<Month>04</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>06</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1873-2550</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>202</Volume>
<Issue>1-2</Issue>
<PubDate>
<Year>2014</Year>
<Month>Apr</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>Veterinary parasitology</Title>
<ISOAbbreviation>Vet. Parasitol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficacy in cats of a novel topical combination of fipronil, (S)-methoprene, eprinomectin, praziquantel, against induced infestations of Echinococcus multilocularis.</ArticleTitle>
<Pagination>
<MedlinePgn>26-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vetpar.2014.02.034</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0304-4017(14)00107-1</ELocationID>
<Abstract>
<AbstractText>Although foxes are the main reservoir of Echinococcus multilocularis, it is recognized that dogs and cats also may become infected. In cats the infection and egg production rates are usually low. Nevertheless, cats are a potential source of transmission of E. multilocularis. Due to the high human medical significance of E. multilocularis infection, it is important in endemic areas that owned cats are dewormed regularly. This paper presents the efficacy results of a new topical formulation, Broadline(®) (Merial) tested against E. multilocularis infection in cats. Two blinded laboratory studies were conducted to evaluate this novel topical combination of fipronil, (S)-methoprene, eprinomectin, and praziquantel against E. multilocularis. In each study, purpose-bred cats were assigned randomly to two treatment groups of 10 cats each: one untreated control group and one group treated at the minimum therapeutic dose of 0.12 mL/kg bodyweight to deliver 10mg fipronil, 12 mg (S)-methoprene, 0.5mg eprinomectin and 10mg praziquantel/kg bodyweight. The cats were inoculated orally with E. multilocularis protoscolices, 22 or 23 days before treatment. Based on necropsy and intestinal worm count, 8 or 11 days after treatment, the two studies confirmed 100% efficacy of Broadline(®) against adult E. multilocularis.</AbstractText>
<CopyrightInformation>Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tielemans</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas, France. Electronic address: eric.tielemans@merial.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Manavella</LastName>
<ForeName>Coralie</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Merial SAS, Centre de Recherche de Saint-Vulbas, 01150 Saint-Vulbas, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Visser</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Merial GmbH, Kathrinenhof Research Center, 83101 Rohrdorf, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Theodore Chester</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Merial Limited, Duluth, GA 30096, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rosentel</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Merial Limited, Duluth, GA 30096, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Vet Parasitol</MedlineTA>
<NlmUniqueID>7602745</NlmUniqueID>
<ISSNLinking>0304-4017</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000977">Antiparasitic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>6490C9U457</RegistryNumber>
<NameOfSubstance UI="D011223">Praziquantel</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>70288-86-7</RegistryNumber>
<NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>75KP30FD8O</RegistryNumber>
<NameOfSubstance UI="C101434">eprinomectin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8B830OJ2UX</RegistryNumber>
<NameOfSubstance UI="D008726">Methoprene</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>QGH063955F</RegistryNumber>
<NameOfSubstance UI="C082360">fipronil</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000977" MajorTopicYN="N">Antiparasitic Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002371" MajorTopicYN="N">Cat Diseases</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004443" MajorTopicYN="N">Echinococcosis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="Y">veterinary</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D048210" MajorTopicYN="N">Echinococcus multilocularis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008726" MajorTopicYN="N">Methoprene</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011223" MajorTopicYN="N">Praziquantel</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011720" MajorTopicYN="N">Pyrazoles</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Cat</Keyword>
<Keyword MajorTopicYN="N">Cestode</Keyword>
<Keyword MajorTopicYN="N">Echinococcus multilocularis</Keyword>
<Keyword MajorTopicYN="N">Efficacy</Keyword>
<Keyword MajorTopicYN="N">Praziquantel</Keyword>
<Keyword MajorTopicYN="N">Topical treatment</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>4</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>4</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>6</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24703072</ArticleId>
<ArticleId IdType="pii">S0304-4017(14)00107-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.vetpar.2014.02.034</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/RenardV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000086 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000086 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Bois
   |area=    RenardV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:24703072
   |texte=   Efficacy in cats of a novel topical combination of fipronil, (S)-methoprene, eprinomectin, praziquantel, against induced infestations of Echinococcus multilocularis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:24703072" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a RenardV1 

Wicri

This area was generated with Dilib version V0.6.27.
Data generation: Tue Mar 28 00:55:51 2017. Site generation: Thu Jan 4 16:57:14 2024